2009
DOI: 10.1542/peds.2008-1871
|View full text |Cite
|
Sign up to set email alerts
|

Recognition of a Kawasaki Disease Shock Syndrome

Abstract: Abstractobjective-We sought to define the characteristics that distinguish Kawasaki disease shock syndrome from hemodynamically normal Kawasaki disease. methods-We collected data prospectively for all patients with Kawasaki disease who were treated at a single institution during a 4-year period. We defined Kawasaki disease shock syndrome on the basis of systolic hypotension for age, a sustained decrease in systolic blood pressure from baseline of ≥20%, or clinical signs of poor perfusion. We compared clinical … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

18
381
4
16

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 344 publications
(419 citation statements)
references
References 26 publications
18
381
4
16
Order By: Relevance
“…20,21 Several factors have been reported to be associated with refractory cases, including younger age, 22 male gender, 23 earlier presentation, 3 initial treatment before day 4 of fever, lower platelets, 3,22 lower hemoglobin, 3,24 higher white blood cell 25 and bands counts, 3 elevated C-reactive protein 3,19,22,24,26,27 and erythrocyte sedimentation rate, 18 elevated lactate dehydrogenase, 19,24 abnormal liver function, 3,19,22,23,26,27 lower serum albumin 23,28,29 and certain biomarkers, 30-33 among others. 3 Thus, failure to reduce inflammation and fever after immunoglobulin therapy are markers for immunoglobulin resistance in Kawasaki disease.…”
Section: Discussionmentioning
confidence: 99%
“…20,21 Several factors have been reported to be associated with refractory cases, including younger age, 22 male gender, 23 earlier presentation, 3 initial treatment before day 4 of fever, lower platelets, 3,22 lower hemoglobin, 3,24 higher white blood cell 25 and bands counts, 3 elevated C-reactive protein 3,19,22,24,26,27 and erythrocyte sedimentation rate, 18 elevated lactate dehydrogenase, 19,24 abnormal liver function, 3,19,22,23,26,27 lower serum albumin 23,28,29 and certain biomarkers, 30-33 among others. 3 Thus, failure to reduce inflammation and fever after immunoglobulin therapy are markers for immunoglobulin resistance in Kawasaki disease.…”
Section: Discussionmentioning
confidence: 99%
“…Kawasaki disease (KD) is a disease of unknown aetiology affecting medium sized blood vessels 1 . It is the commonest type of acquired heart disease in children and 15-25% of patients have coronary artery involvement 2 .…”
Section: Introductionmentioning
confidence: 99%
“…It is the commonest type of acquired heart disease in children and 15-25% of patients have coronary artery involvement 2 . Kawasaki disease shock syndrome (KDSS) is a rare haemodynamically unstable phenomenon in the acute stages of KD which was first described by Kenagaye et al in 2009 1 . Possible causes for the haemodynamic instability are vasculitis with capillary leak, myocardial dysfunction and cytokine dysregulation 1 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The cause of KDSS is unknown as KD, but capillary leakage due to vasculitis, myocardial dysfunction, and cytokine dysregulation are thought to be responsible. The patients are hypotensive and show signs and symptoms of poor perfusion 3 . This report describes two children with KDSS, the first one had the diagnosis of KD but the second one initially had the diagnosis of toxic shock syndrome.…”
mentioning
confidence: 99%